James Waxmonsky, MD
Enriched profileProfessor of Psychiatry; Division Chief, Child & Adolescent Psychiatry; University Chair in Child Psychiatry; Vice Chair for Children's Services · Penn State College of Medicine
James Waxmonsky is Professor of Psychiatry; Division Chief, Child & Adolescent Psychiatry; University Chair in Child Psychiatry; Vice Chair for Children's Services at Penn State College of Medicine. OpenAlex indexes 173 publications with 5,175 citations (h-index 41); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
James Waxmonsky, MD, is Professor of Psychiatry at Penn State College of Medicine / Penn State Health Milton S. Hershey Medical Center. The public record shows 173 publications with 5,175 citations (h-index 41), centered on Psychiatry. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 4 companies, 1 NIH-funded awards (2025–2026).
- Most recent indexed publication: 2023 · Research on child and adolescent psychopathology
- Top research focus: Psychiatry
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Study to Evaluate Safety & Efficacy of d-Amphetamine Transdermal System vs Placebo in Children & Adolescents With ADHD
Sponsor: Noven Pharmaceuticals, Inc.
- Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?
Sponsor: Florida International University
- Novel Approach to Stimulant Induced Weight Suppression and Its Impact on Growth
Sponsor: Florida International University
Industry payments
Updated 27 Aug 2026
4 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- Collegium Pharmaceutical, Inc.Program year20251 payment
- IRONSHORE PHARMACEUTICALS INC.Program year20241 payment
- Ironshore Pharmaceuticals Inc.Program year20231 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Azaspirodecanedione derivatives57.7%Buspirone Hcl100%Part D<11 patientsAminoketone42.3%Bupropion Xl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2025–2026 per NIH RePORTER. The latest:
- Identification of Neural Markers of Aggression and Irritability and Their Capacity to Predict Treatment Response to CNS Stimulant Medication in Youth with ADHD
Pennsylvania State Univ Hershey Med Ctr
FY2026$677,683R01MH137647 - Identification of Neural Markers of Aggression and Irritability and Their Capacity to Predict Treatment Response to CNS Stimulant Medication in Youth with ADHD
Pennsylvania State Univ Hershey Med Ctr
FY2025$752,854R01MH137647 - Examining Tolerance to CNS Stimulants in ADD
Florida International University
FY2014$652,494R01MH099030
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Single and Combined Effects of Multiple Intensities of Behavioral Modification and Methylphenidate for Children with ADHD in the Home Setting.
Research on child and adolescent psychopathology
Clinical Trial2023 - Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD.
Journal of attention disorders
Clinical Trial2022 - Associations among ADHD symptoms, ODD symptoms, and borderline personality features: A network analysis.
Research on child and adolescent psychopathology
Article2022 - The Impact of Irritability and Callous Unemotional Traits on Reward Positivity in Youth with ADHD and Conduct Problems.
Research on child and adolescent psychopathology
Article2022 - The Role of Parental Knowledge and Attitudes about ADHD and Perceptions of Treatment Response in the Treatment Utilization of Families of Children with ADHD.
Evidence-based practice in child and adolescent mental health
Article2020
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennstatehealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennstatehealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennstatehealth.org ↗
- Board Certified
American Board of Psychiatry and Neurology - Psychiatry
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - Board Certified
American Board of Psychiatry and Neurology - Child & Adolescent Psychiatry
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- Medical Director
Telephonic Psychiatry Services Program, Penn State Health (central/northeastern PA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennstatehealth.org ↗ - Director
Division of Child Outpatient Services, Penn State Dept. of Psychiatry and Behavioral Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pure.psu.edu ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pure.psu.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pure.psu.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sites.psu.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.